Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

By Du Juan   Näsman Anders   Carlson Joseph W.   Ramqvist Torbjörn   Dalianis Tina  

Acta Oncologica, Vol. 50, Iss. 8, 2011-11 ,pp. : 1215-1219

Informa Healthcare

Access to resources Recommend Favorite

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18

By Chen Wen  

Cancer Causes and Control, Vol. 20, Iss. 9, 2009-11 ,pp. : 1705-1713

Springer Publishing Company

Access to resources Recommend Favorite

A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas

By Koyamatsu Y.   Yokoyama M.   Nakao Y.   Fukuda K.   Saito T.   Matsukuma K.   Iwasaka T.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 547-551

Elsevier

Access to resources Recommend Favorite

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination

By Franco Eduardo L   Ferenczy Alex  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 319-327

Future Medicine

Access to resources Recommend Favorite

The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical Cancer

By Fisher S.G.   Benitez-Bribiesca L.   Nindl I.   Stockfleth E.   Muller M.   Wolf H.   Perez-Garcia F.   Guzman-Gaona J.   Gutierrez-delgado F.   Irvin W.   Gissmann L.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 73-78

Academic Press

Access to resources Recommend Favorite